Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
- · 50d
- Not stated
- Not stated
- Not stated
Official announcement on nih_guide · opens the funder's page. Always confirm dates there.
Summary
The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with tobacco use in the U.S. This notice of funding opportunity (NOFO) allows investigators… […]
Other topics in this solicitation
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)
NHLBI Program Project Applications (P01 Clinical Trials Optional)
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)
$350k
Medical Scientist Training Program (MSTP) (T32)
Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
Clinical and Translational Science Award (UM1 Clinical Trial Optional)
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- The scoring framework for this mechanism — we have not extracted per-criterion detail for this specific announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)
$350k
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k